Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Okin

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE studyG de Simone, P M Okin, E Gerdts, et al.
Journal of Hypertension|August 23, 2000
Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertensionR B Devereux, M J Roman, V Palmieri, et al.
Journal of the American College of Cardiology|August 14, 2001
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End pointP M Okin, R B Devereux, M S Nieminen, et al.
Annals of Surgery|October 16, 1999
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNAT K Rosengart, L Y Lee, S R Patel, et al.
The Annals of Thoracic Surgery|September 2, 2000
Transmyocardial laser revascularization with excimer laser: clinical results at 1 yearL Y Lee, M F O'Hara, E B Finnin, et al.
Journal of Human Hypertension|April 2, 2004
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE studyP M Okin, R B Devereux, J E Liu, et al.
The American Journal of Cardiology|December 15, 1996
Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study)A J Oopik, M Dorogy, R B Devereux, et al.
Blood Pressure|July 27, 2001
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE StudyR B Devereux, J Bella, K Boman, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE studyG de Simone, P M Okin, E Gerdts, et al.
Journal of Hypertension|August 23, 2000
Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertensionR B Devereux, M J Roman, V Palmieri, et al.
Journal of the American College of Cardiology|August 14, 2001
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End pointP M Okin, R B Devereux, M S Nieminen, et al.
Annals of Surgery|October 16, 1999
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNAT K Rosengart, L Y Lee, S R Patel, et al.
The Annals of Thoracic Surgery|September 2, 2000
Transmyocardial laser revascularization with excimer laser: clinical results at 1 yearL Y Lee, M F O'Hara, E B Finnin, et al.
Journal of Human Hypertension|April 2, 2004
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE studyP M Okin, R B Devereux, J E Liu, et al.
The American Journal of Cardiology|December 15, 1996
Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study)A J Oopik, M Dorogy, R B Devereux, et al.
Blood Pressure|July 27, 2001
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE StudyR B Devereux, J Bella, K Boman, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Pageof 10